Related references
Note: Only part of the references are listed.Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease
Stephen Salloway et al.
JAMA NEUROLOGY (2022)
Nanozyme scavenging ROS for prevention of pathologic α-synuclein transmission in Parkinson's disease
Yu-Qing Liu et al.
NANO TODAY (2021)
Strategies for delivering therapeutics across the blood-brain barrier
Georg C. Terstappen et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Lymphocyte Activation Gene 3 (Lag3) Contributes to α-Synucleinopathy in α-Synuclein Transgenic Mice
Hao Gu et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2021)
The Prion-Like Spreading of Alpha-Synuclein in Parkinson's Disease: Update on Models and Hypotheses
Asad Jan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Mechanistic basis for receptor-mediated pathological α-synuclein fibril cell-to-cell transmission in Parkinson's disease
Shengnan Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
A Small Virus to Deliver Small Antibodies: New Targeted Therapies Based on AAV Delivery of Nanobodies
Noelia Silva-Pilipich et al.
MICROORGANISMS (2021)
Characterization of novel conformation-selective alpha-synuclein antibodies as potential immunotherapeutic agents for Parkinson's disease
Michael X. Henderson et al.
NEUROBIOLOGY OF DISEASE (2020)
Applying Antibodies Inside Cells: Principles and Recent Advances in Neurobiology, Virology and Oncology
Congcong Zhang et al.
BIODRUGS (2020)
Molecular Mediation of Prion-like α-Synuclein Fibrillation from Toxic PFFs to Nontoxic Species
Longgang Jia et al.
ACS APPLIED BIO MATERIALS (2020)
Early Stage Alpha-Synuclein Amyloid Fibrils are Reservoirs of Membrane-Binding Species
Thomas Skamris et al.
SCIENTIFIC REPORTS (2019)
Antibodies against alpha-synuclein: tools and therapies
Nishant N. Vaikath et al.
JOURNAL OF NEUROCHEMISTRY (2019)
α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies
Michael X. Henderson et al.
NEUROSCIENCE LETTERS (2019)
A toolbox of nanobodies developed and validated for use as intrabodies and nanoscale immunolabels in mammalian brain neurons
Jie-Xian Dong et al.
ELIFE (2019)
Dementia with Lewy bodies - from scientific knowledge to clinical insights
Nikitas A. Arnaoutoglou et al.
NATURE REVIEWS NEUROLOGY (2019)
Preclinical development of a high affinity α-synuclein antibody, MEDI1341, that can enter the brain, sequester extracellular α-synuclein and attenuate α-synuclein spreading in vivo
Darren J. Schofield et al.
NEUROBIOLOGY OF DISEASE (2019)
Current Approaches and Future Perspectives for Nanobodies in Stroke Diagnostic and Therapy
Larissa Jank et al.
ANTIBODIES (2019)
Yeast surface display platform for rapid discovery of conformationally selective nanobodies
Conor McMahon et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Yeast surface display platform for rapid discovery of conformationally selective nanobodies
Conor McMahon et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
The structural basis of nanobody unfolding reversibility and thermoresistance
Patrick Kunz et al.
SCIENTIFIC REPORTS (2018)
Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti-a-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease A Randomized Clinical Trial
Joseph Jankovic et al.
JAMA NEUROLOGY (2018)
Poly(ADP-ribose) drives pathologic α-synuclein neurodegeneration in Parkinson's disease
Tae-In Kam et al.
SCIENCE (2018)
Targeted Intracellular Delivery of Antibodies: The State of the Art
Tatiana A. Slastnikova et al.
FRONTIERS IN PHARMACOLOGY (2018)
The use of accelerometry as a tool to measure disturbed nocturnal sleep in Parkinson's disease
Sarah McGregor et al.
NPJ PARKINSONS DISEASE (2018)
Antigen Masking During Fixation and Embedding, Dissected
Carla Rossana Scalia et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2017)
First-in-human assessment of PRX002, an anti--synuclein monoclonal antibody, in healthy volunteers
Dale B. Schenk et al.
MOVEMENT DISORDERS (2017)
A light- and calcium-gated transcription factor for imaging and manipulating activated neurons
Wenjing Wang et al.
NATURE BIOTECHNOLOGY (2017)
α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies
Yvette C. Wong et al.
NATURE MEDICINE (2017)
Activation of tyrosine kinase c-Abl contributes to α-synuclein-induced neurodegeneration
Saurav Brahmachari et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Bifunctional Anti-Non-Amyloid Component α-Synuclein Nanobodies Are Protective In Situ
David C. Butler et al.
PLOS ONE (2016)
Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain
Wen Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3
Xiaobo Mao et al.
SCIENCE (2016)
NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies
Sandrine Moutel et al.
ELIFE (2016)
α-Synuclein strains cause distinct synucleinopathies after local and systemic administration
W. Peelaerts et al.
NATURE (2015)
Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation
Ianai Fishbein et al.
BRAIN (2014)
Reducing C-Terminal-Truncated Alpha-Synuclein by Immunotherapy Attenuates Neurodegeneration and Propagation in Parkinson's Disease-Like Models
Dora Games et al.
JOURNAL OF NEUROSCIENCE (2014)
Addition of exogenous α-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous α-synuclein to Lewy body and Lewy neurite-like aggregates
Laura A. Volpicelli-Daley et al.
NATURE PROTOCOLS (2014)
α-Synuclein Immunotherapy Blocks Uptake and Templated Propagation of Misfolded α-Synuclein and Neurodegeneration
Hien T. Tran et al.
CELL REPORTS (2014)
Intracerebroventricular Viral Injection of the Neonatal Mouse Brain for Persistent and Widespread Neuronal Transduction
Ji-Yoen Kim et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2014)
Nanobodies: Natural Single-Domain Antibodies
Serge Muyldermans
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 82 (2013)
Nanobodies Raised against Monomeric α-Synuclein Distinguish between Fibrils at Different Maturation Stages
Tim Guilliams et al.
JOURNAL OF MOLECULAR BIOLOGY (2013)
The many faces of alpha-synuclein: from structure and toxicity to therapeutic target
Hilal A. Lashuel et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Intrabodies as Neuroprotective Therapeutics
Anne Messer et al.
NEUROTHERAPEUTICS (2013)
Expression of recombinant antibodies
Andre Frenzel et al.
FRONTIERS IN IMMUNOLOGY (2013)
A bacterial-two-hybrid selection system for one-step isolation of intracellularly functional Nanobodies
Mireille Pellis et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2012)
Antibody-Aided Clearance of Extracellular α-Synuclein Prevents Cell-to-Cell Aggregate Transmission
Eun-Jin Bae et al.
JOURNAL OF NEUROSCIENCE (2012)
Disulfide bond structures of IgG molecules Structural variations, chemical modifications and possible impacts to stability and biological function
Hongcheng Liu et al.
MABS (2012)
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
Kelvin C. Luk et al.
SCIENCE (2012)
Binding Modes of Thioflavin T Molecules to Prion Peptide Assemblies Identified by Using Scanning Tunneling Microscopy
Xiaobo Mao et al.
ACS CHEMICAL NEUROSCIENCE (2011)
α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation
Tim Bartels et al.
NATURE (2011)
Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death
Laura A. Volpicelli-Daley et al.
NEURON (2011)
Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
Eliezer Masliah et al.
PLOS ONE (2011)
A soluble α-synuclein construct forms a dynamic tetramer
Wei Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Modulation of protein properties in living cells using nanobodies
Axel Kirchhofer et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
H-1, C-13 and N-15 assignments of a camelid nanobody directed against human alpha-synuclein
Anneleen Vuchelen et al.
BIOMOLECULAR NMR ASSIGNMENTS (2009)
Intracellular targeting and clearance of oligomeric alpha-synuclein alleviates toxicity in mammalian cells
Bin Yuan et al.
NEUROSCIENCE LETTERS (2009)
Exogenous α-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells
Kelvin C. Luk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Disulfide bond introduction for general stabilization of immunoglobulin heavy-chain variable domains
Dirk Saerens et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Lewy body dementia and Parkinson's disease with dementia
Richard Dodel et al.
JOURNAL OF NEUROLOGY (2008)
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation
Jia-Yi Li et al.
NATURE MEDICINE (2008)
Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease
Jeffrey H. Kordower et al.
NATURE MEDICINE (2008)
Isolation of a human single chain antibody fragment against oligomeric α-synuclein that inhibits aggregation and prevents α-synuclein-induced toxicity
Sharareh Emadi et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Isolating and engineering human antibodies using yeast surface display
Ginger Chao et al.
NATURE PROTOCOLS (2006)
Mechanism of thioflavin T binding to amyloid fibrils
R Khurana et al.
JOURNAL OF STRUCTURAL BIOLOGY (2005)
Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation
S Gispert et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2003)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Single-domain antibody fragments with high conformational stability
M Dumoulin et al.
PROTEIN SCIENCE (2002)
α-Synuclein is phosphorylated in synucleinopathy lesions
H Fujiwara et al.
NATURE CELL BIOLOGY (2002)
Membrane-bound α-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form
HJ Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Synucleins are developmentally expressed, and α-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons
DD Murphy et al.
JOURNAL OF NEUROSCIENCE (2000)
Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system
A Abeliovich et al.
NEURON (2000)
Share Paper
